Everolimus (RAD001) concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients

Authors
Category Primary study
JournalJournal of the American Society of Nephrology
Year 2008
This article has no abstract
Epistemonikos ID: d93715ed186177cf18c54fb7bac3128cea347f1a
First added on: Nov 26, 2018